GLYCOMIMETICS INC's ticker is GLYC and the CUSIP is 38000Q102. A total of 31 filers reported holding GLYCOMIMETICS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $196,000 | -50.9% | 65,061 | -38.7% | 0.00% | -50.0% |
| Q4 2020 | $399,000 | -27.3% | 106,163 | -40.6% | 0.00% | -33.3% |
| Q3 2020 | $549,000 | -18.4% | 178,859 | -0.1% | 0.00% | -25.0% |
| Q2 2020 | $673,000 | +50.6% | 179,051 | -8.8% | 0.00% | +33.3% |
| Q1 2020 | $447,000 | -28.6% | 196,284 | +66.0% | 0.00% | 0.0% |
| Q4 2019 | $626,000 | +961.0% | 118,270 | +1367.9% | 0.00% | – |
| Q2 2016 | $59,000 | -94.4% | 8,057 | -87.5% | 0.00% | -100.0% |
| Q1 2014 | $1,056,000 | – | 64,671 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 3,000,000 | $4,500,000 | 0.69% |
| Artal Group S.A. | 8,589,064 | $12,884 | 0.55% |
| NEA Management Company, LLC | 4,764,440 | $7,146,660 | 0.55% |
| BVF INC/IL | 9,544,262 | $14,316,393 | 0.39% |
| Intellectus Partners, LLC | 61,975 | $92,963 | 0.03% |
| ACUTA CAPITAL PARTNERS, LLC | 27,500 | $41,250 | 0.03% |
| Sargent Investment Group, LLC | 58,000 | $87,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 93,785 | $141 | 0.01% |
| AXA S.A. | 1,625,698 | $2,438,547 | 0.01% |
| XTX Topco Ltd | 32,722 | $49,083 | 0.01% |